Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Venous Thromboembolism 7Venous Thrombosis 5Pulmonary Embolism 4Neoplasms 4Thromboembolism 2Lung Neoplasms 2Thrombosis 1Thrombocytopenia 1Pancreatic Neoplasms 1Multiple Myeloma 1Lymphoma 1Liver Neoplasms 1Kidney Neoplasms 1Hemorrhage 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1Brain Neoplasms 1

Interventions

Tranexamic Acid 13Sodium Chloride 4Misoprostol 4Saline Solution 3Enoxaparin 3carbetocin 2Tourniquets 2Ringer's Lactate 2Oxytocin 2Endoscopic Mucosal Resection 2Dalteparin 2maleimide-polyethylene glycol-modified hemoglobin, MP4 1bemiparin 1Vitamin B 6 1Vasopressins 1Uterine Myomectomy 1Uterine Artery Embolization 1Tinzaparin 1Thoracic Surgery, Video-Assisted 1Terlipressin 1Sutures 1Surgicel 1Standard of Care 1Solutions 1Sensitivity Training Groups 1Rivaroxaban 1Ringer's Solution 1Radiotherapy 1Proton Pump Inhibitors 1Palliative Care 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Hemorrhage × Tinzaparin × Clear all
NCT04731558 2025-02-14

PREPOSTEROUS

Helsinki University Central Hospital

Phase 4 Recruiting
1,012 enrolled
Gastrointestinal

Hemorrhage, Liver Neoplasms, Pulmonary Embolism, Venous Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡